BioRestorative Therapies receives Nasdaq delisting notice for late 10-Q filing

BioRestorative Therapies, Inc.

Received Nasdaq delinquency notice on Aug 21, 2026 for failure to file Form 10-Q for Q2 2026.
Must submit compliance plan by Oct 20, 2026; Nasdaq may grant extension until Feb 16, 2027.
Listing continues on Nasdaq Capital Market under BRTX; no immediate delisting effect.
Company plans to file 10-Q and submit plan; may appeal if plan rejected.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.